Search Results - "Antonini, Marcelo"

Refine Results
  1. 1

    Systematic Review of Nomograms Used for Predicting Pathological Complete Response in Early Breast Cancer by Antonini, Marcelo, Pannain, Gabriel Duque, Mattar, André, Ferraro, Odair, Lopes, Reginaldo Guedes Coelho, Real, Juliana Monte, Okumura, Lucas Miyake

    Published in Current oncology (Toronto) (01-10-2023)
    “…Pathological complete response (pCR) is an important surrogate outcome to assess the effects of neoadjuvant chemotherapy (NAC). Nomograms to predict pCR have…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Tolerability of endometriosis medical treatment: a comparison between combined hormonal contraceptives and progestins by da Costa Pinheiro, Denise Joffily Pereira, Pereira, Ana Maria Gomes, Antonini, Marcelo, Maria Albuquerque Salgado, Isabella, Dias, Alexandre Torchio, Lopes, Reginaldo Guedes Coelho

    Published in BMC women's health (23-09-2023)
    “…Endometriosis is a chronic inflammatory disease that occurs in women of reproductive age. Much of the treatment involves hormone therapy that suppresses the…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Knowledge related to breast cancer screening programs by physicians in Brazil by Antonini, Marcelo, Pannain, Gabriel Duque, Souza, Gabriela Silva Solino de, Ferraro, Odair, Mattar, Andre, Lopes, Reginaldo Guedes Coelho, Real, Juliana Monte

    Published in Einstein (São Paulo, Brazil) (2024)
    “…Antonini et al. evaluated gynecologists', obstetricians', and family and community physicians knowledge of breast cancer screening and their adherence to…”
    Get full text
    Journal Article
  6. 6

    Analyzing Neoadjuvant Chemotherapy Effects in HER2-Low Breast Cancer: Real World Data by Antonini, Marcelo, Mattar, Andre, Richter, Fernanda G, Ramos, Marcellus N, Teixeira, Marina D, Pantarotto, Nathalia N, Matta, Nadia F, Amorim, Andressa G, Pinheiro, Denise J, Lopes, Reginaldo C

    Published in Curēus (Palo Alto, CA) (04-05-2024)
    “…Neoadjuvant chemotherapy (NAC) can be used as upfront therapy in aggressive breast cancer (BC). human epidermal growth factor receptor 2 (HER2)-low BC, defined…”
    Get full text
    Journal Article
  7. 7

    Does Pink October really impact breast cancer screening? by Antonini, Marcelo, Pinheiro, Denise Joffily Pereira da Costa, Salerno, Gisela Rosa Franco, Matos, Ana Beatriz Tavares de Moura Brasil, Ferraro, Odair, Mattar, André, Lopes, Reginaldo Guedes Coelho, Real, Juliana Monte

    “…This study aims to evaluate the impact of the Pink October Campaign on the increase in mammographic screening in Brazil. Ecological observational study, based…”
    Get full text
    Journal Article
  8. 8

    Impact of the COVID-19 pandemic on the breast cancer early diagnosis program in Brazil by Antonini, Marcelo, Pinheiro, Denise J.P. da C., Matos, Ana B.T. de M.B., Ferraro, Odair, Mattar, Andre, Okumura, Lucas M., Lopes, Reginaldo G.C., Real, Juliana M.

    Published in Preventive medicine reports (01-04-2023)
    “…During the COVID-19 pandemic, several screening exams were postponed, including mammograms. The aim of this study was to evaluate the impact of COVID-19 in…”
    Get full text
    Journal Article
  9. 9

    Abstract PS6-23: Comparison between the American joint committee on cancer (AJCC) anatomic and prognostic stages for breast cancer by Cardoso, Mariana Soares, Antonini, Marcelo, Ferraro, Odair, de Paula Solino, Matheus, Cabral, Samira Marcondes, de Barros Vasconcelos, Raissa Naiara Alves

    Published in Cancer research (Chicago, Ill.) (15-02-2021)
    “…Introduction: The knowledge regarding the tumor biology of breast cancer has grown substantially and resulted in the identification of different breast cancer…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Abstract PO2-17-10: Metaplastic breast cancer: description of 16 cases treated at a reference center and review of the literature by Mattar, Andre, Antonini, Marcelo, Diogenes, Marina, Amorim, Andressa, Cavalcante, Francisco Pimentel, Gebrim, Luiz Henrique

    Published in Cancer research (Chicago, Ill.) (02-05-2024)
    “…Background: Metaplastic breast carcinomas (MBC) are very rare and represent less than 1% of all invasive breast carcinomas. It is a heterogeneous neoplasm…”
    Get full text
    Journal Article
  14. 14

    Abstract PO3-09-12: Exploring Gender-Specific Patterns of Breast Cancer in Brazil: A Comparative Epidemiological Study by Antonini, Marcelo, Pannain, Gabriel, Buttenbender, Steffi, Mattar, Andre, Lopes, Reginaldo Coelho, Ferraro, Odair

    Published in Cancer research (Chicago, Ill.) (02-05-2024)
    “…Introduction: Male breast cancer constitutes approximately 1% of all breast cancer cases, and limited studies have focused on this population, resulting in a…”
    Get full text
    Journal Article
  15. 15

    Abstract PO2-17-08: A RETROSPECTIVE ANALYZES OF 4,885 PATIENTS OF HORMONAL RECEPTOR POSITIVE, HER2 NEGATIVE BREAST CANCER TREATED IN A REFERENCE CENTER, A REAL-WORLD DATA by Mattar, Andre, Antonini, Marcelo, Diogenes, Marina, Amorim, Andressa, Cavalcante, Francisco Pimentel, Gebrim, Luiz Henrique

    Published in Cancer research (Chicago, Ill.) (02-05-2024)
    “…Background: Hormonal receptor positive Her2 negative also described as luminal breast cancer (LBC) is the most frequent tumor corresponding to about 60-65% of…”
    Get full text
    Journal Article
  16. 16

    Abstract PO2-07-12: Analysis Of Malignity Rates Of Percutaneous Biopsy In Lymph Nodes Of Breast Cancer Patients by Diogenes, Marina, Amorim, Andressa, MATTAR, ANDRE, ANTONINI, MARCELO, Gebrim, Luiz Henrique, LOPES, REGINALDO COELHO, Damous, Luciana

    Published in Cancer research (Chicago, Ill.) (02-05-2024)
    “…BACKGROUND: The evaluation of regional lymph nodes in patients with breast cancer is one of the main predictive and prognostic factors for treatment. The…”
    Get full text
    Journal Article
  17. 17

    Abstract PO2-17-02: Can body mass index be a complete pathological response predictor in breast cancer patients submitted to neoadjuvant chemotherapy? A real-world data trial by Richter, Fernanda Grace Bauk, Mattar, Andre, Antonini, Marcelo, Real, Juliana, Gebrim, Luis Henrique, Lopes, Reginaldo Coelho

    Published in Cancer research (Chicago, Ill.) (02-05-2024)
    “…Background: Breast cancer is a prevalent disease, and Its incidence has increased annually worldwide. The prognosis depends on several factors, such as patient…”
    Get full text
    Journal Article
  18. 18

    Abstract PO4-16-10: Overall survival in sentinel node biopsy and axillary dissection: a real-world data by Pares, Renata, Mattar, Andre, de Lima, Juliana, Antonini, Marcelo, Cavalcante, Francisco Pimentel, Gebrim, Luiz Henrique

    Published in Cancer research (Chicago, Ill.) (02-05-2024)
    “…Background: Information about the status of the axilla (presence or absence of lymph node disease) is important for breast cancer (BC) treatment…”
    Get full text
    Journal Article
  19. 19

    Abstract PO2-17-09: Overall survival differences between HER2 Low and other breast cancer subtypes in a reference center in Brazil by Mattar, Andre, Amorim, Andressa, Diogenes, Marina, Antonini, Marcelo, Cavalcante, Francisco Pimentel, Gebrim, Luiz Henrique

    Published in Cancer research (Chicago, Ill.) (02-05-2024)
    “…Background: Breast cancer (BC) is a heterogeneous disease, and its subtypes have different prognosis and diverse responses to endocrine therapy and…”
    Get full text
    Journal Article
  20. 20